Indefinite Delivery Contract 36C24221D0091

Award Date 4/30/21
Last Date to Order 4/30/25
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The federal contract IDV award is to Biomerieux Inc., a global leader in in vitro diagnostics, through its Biomerieux, Inc. division. The contract, awarded by the Veterans Integrated Service Network 6 (VISN 6), a civilian agency under the Department of Veterans Affairs, is for the delivery of VITEK microorganism identification and antibiotic susceptibility testing products and services. The contract does not have a set-aside designation, as Biomerieux is often the sole-source provider for its...
This federal contract IDV award is a Blanket Purchase Agreement (BPA) awarded by the U.S. Department of Veterans Affairs (VA), Veterans Integrated Service Network 2 (VISN 2), to Biomerieux Inc., a global leader in in vitro diagnostics. The contract, valued at up to $6,557,011.80, covers the procurement of Biomerieux's proprietary BioFire Panels and Verification Kits for infectious disease testing and pathogen detection across VA healthcare operations. The contract does not have a set-aside...
This single-award Indefinite Delivery Contract (IDC) was issued by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 21 (VISN 21) to Biomerieux Inc., a global diagnostics manufacturer, to provide an Automated Blood Culture System and associated reagents. The $2,000,000 contract has a period of performance through September 30, 2025. Biomerieux will deliver its proprietary VITEK, BioFire, and VIDAS platforms, consumables, and technical support services to support...
The U.S. Department of Veterans Affairs (VA) has awarded a single-award, indefinite delivery contract to Biomerieux Inc., a global leader in in vitro diagnostics, to provide bacterial identification and antibiotic susceptibility testing services to the VA's Veterans Integrated Service Network 2 (VISN 2). The contract, valued at a ceiling of $2,366,377.51, has an ultimate completion date of March 31, 2026 and does not utilize any set-aside designations. Under this IDC, Biomerieux Inc., through...
The federal contract Indefinite Delivery Vehicle (IDV) with ID 36C25625D0016 is a single-award contract awarded to Biomerieux Inc., a global leader in in vitro diagnostics, through its Biomerieux, Inc. division. The contract, which has a ceiling value of $12,000.96 and a period of performance through February 28, 2030, is for a service agreement to provide the Veterans Integrated Service Network 16 (VISN 16) with Biomerieux's PREVI Color Gram diagnostic solutions. Biomerieux Inc. is a...
This Indefinite Delivery Contract was awarded by the U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network 23 (VISN 23) to Biomerieux Inc., doing business as Vitek Systems, Inc. The contract has a ceiling value of $35,304.00 and a period of performance ending on September 30, 2025. The contract is for the provision of blood culture supplies and equipment to support the Minneapolis VA Health Care System. This delivery order was issued under a broader Indefinite Delivery...
Biomerieux Inc., a global leader in in vitro diagnostics, was awarded a single-award Indefinite Delivery Contract (IDC) by the Department of Veterans Affairs' Veterans Integrated Service Network (VISN) 23. The contract, valued at $135,660.00, is for the maintenance and support of Biomerieux's specialized diagnostic equipment and platforms installed at VA healthcare facilities. The contract has an ultimate completion date of September 30, 2027, with the first two task orders valued at...
This indefinite delivery contract (IDC) was awarded by the Department of Veterans Affairs, Veterans Health Administration, Network Contracting Office 6 to Biomerieux Inc. for the provision of the BACT/ALERT VIRTUO fully automated blood culture testing system, associated consumables, training, and support services. The contract is a sole source award to Biomerieux Inc., the original equipment manufacturer, as these specialized items are only available from this single source without...
The Department of Veterans Affairs (VA) awarded an Indefinite Delivery Contract (IDC) to Biomerieux Inc., a global leader in in vitro diagnostics, to provide a blood culture system, including reagents, equipment, middleware, servers, and support services for the VA's Veterans Integrated Service Network 15 (VISN 15). The IDC, valued at up to $2,197,150.10, has a period of performance through July 31, 2025 and does not have a set-aside designation. Under this IDC, the VA has awarded multiple...
The Department of Veterans Affairs (VA) has awarded a single-award Indefinite Delivery Contract (IDC) to Biomerieux Inc. for VISN 8 Molecular Pathogen Detection. The contract, valued at $31,825,821.12, has an ultimate completion date of January 12, 2030, and was awarded on January 13, 2025. Under this IDC, Biomerieux Inc., through its Biomerieux, Inc. Division, will provide in-vitro diagnostic test panels, equipment, and related services to support molecular pathogen detection capabilities at...
  • 36C24221D0091
    Indefinite Delivery Contract
  • 5
    Federal Contract Awards

The federal contract IDV award 36C24221D0091 is a single-award indefinite delivery contract held by Biomerieux Inc., a global leader in in vitro diagnostics. The contract, valued at $349,650.00, was awarded by the Veterans Integrated Service Network 2 (VISN 2) of the U.S. Department of Veterans Affairs.

The contract's purpose is to provide VISN 2 with Biomerieux's BacT/ALERT VIRTUO Blood Culture System and associated consumables on a cost-per-test basis to support the pathology and laboratory needs of VA healthcare facilities in the Eno Valley, North Carolina region. The 5-year contract includes firm-fixed-price delivery orders for the BacT/ALERT culture systems, media supplies, and other diagnostic products. Biomerieux holds several Indefinite Delivery Vehicles with the VA and other federal agencies, enabling efficient procurement of its specialized microbiology testing solutions for government healthcare operations. The contract does not have any set-aside designations, as Biomerieux is typically the sole-source provider for its proprietary diagnostic platforms.

Generated 4/12/25, 10:54 AM